+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 2 Actively Recruiting clinical trials

U

Actively Recruiting

Healthy Volunteer

Researchers are evaluating the use of artificial intelligence-driven virtual standardized patients VSPs to improve the ability of primary care doctors in China to manage common pediatric diseases. The study addresses challenges in Chinas pediatric healthcare system, including limited capacity in primary care and a lack of effective training tools. It involves a randomized controlled trial with over 459 doctors from various specialties across more than 10 provinces, aiming to enhance pediatric care through innovative training methods. The trial involves three groups one using a virtual patient platform where doctors interact with AI-driven simulated patients covering diseases like pneumococcal pneumonia, rotavirus enteritis with hypovolemic shock, hand-foot-and-mouth disease, acute appendicitis, and respiratory failure another group uses case teaching manuals, and the third group uses case teaching videos. Participants engage in a two-week learning period with their assigned training method. During the study, doctors management skills will be assessed through clinical vignettes to measure adherence to best clinical practice guidelines. Researchers will monitor diagnosis accuracy, examination scores relevant to disease handling, and doctors focus on patient needs. The study runs for about six months and includes over 300 primary healthcare institutions to ensure wide representation. The trial also evaluates the acceptance and costs of the training methods used.

All AgesAll GendersPhase Not Applicable
3 locations
A

Actively Recruiting

Researchers are studying the prevalence of chronic obstructive pulmonary disease COPD among participants aged 40 years or older who have one of three types of cardiovascular diseases coronary heart disease, atrial fibrillation, or chronic heart failure. This multi-center, prospective, interventional study aims to understand how cardiopulmonary co-management affects the short-term health outcomes of participants with both cardiovascular disease and COPD. Approximately 3,000 participants will be enrolled, with about 1,000 in each disease cohort. The study intervention includes guideline education and implementation at both the investigator and patient levels. Investigators receive education on COPD and cardiovascular disease about four weeks before enrolling participants. After enrollment, cardiologists and pulmonologists provide disease education every four weeks, along with collaborative treatment management for participants with both conditions. Participants are followed up every four weeks throughout the study. During the study, participants will undergo spirometry testing, complete questionnaires, and have various health measures recorded, including hospitalization rates and scores related to heart and lung function. Researchers will also monitor lung function tests, blood markers, and medication use at baseline and at weeks 4, 8, and 12. The primary outcome is the number and percentage of participants with COPD across the cardiovascular disease cohorts. The study includes short-term follow-up over 12 weeks to observe treatment and health changes.

Age: 40Years +All GendersPhase Not Applicable
85 locations